NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
Back to search
Official data from USPTO
WUXI BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WUXI BIOLOGICS
ST13
US500000098582091Class
1, 40, 42
Filing
98582091
Registration
7875814
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/29/2025
Trademark type
Word
Nice classes
1, 40, 42
Filing date
06/03/2024
Registration date
07/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
DUNDALK, CO LOUTH, IE
Examiner
WATTS-FITZGERALD, CAITLIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
WUXI BIOLOGICS IRELAND LIMITED
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for use in industry and science; biological preparations to be used for protein productionother than for medical or veterinary purposesprotein for industrial useprotein in raw material form for scientific and medical researchprotein arrays for scientific and medical researchproteins for use in manufacture; chemical reagentsother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; cultures of microorganismsother than for medical and veterinary use; chemical preparations for scientific purposesother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes
Class 40
Chemical distillation services in the field of chemical reagents; Custom manufacture of antibody drugs; Custom manufacture of biological preparations in the nature of fungicides and cancer drugs; Custom manufacture of cancer medicines; Custom manufacture of pharmaceuticals
Class 42
Consulting services in the field of technological product development; Research and development of new products for others; Research and developments of new products; Scientific research and development; Pharmaceutical drug development services; Pharmaceutical research services; Biochemical research and analysis; Development of pharmaceutical preparations and medicines; Research and development services in the field of antibodies; Biological research
Publications
History of USPTO decisions and trademark events.
26 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/29/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/25/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
06/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
06/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/25/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/24/2025
GNFR
FINAL REFUSAL E-MAILED
06/24/2025
CNFR
FINAL REFUSAL WRITTEN
06/24/2025
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/20/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/17/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/17/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/17/2024
GNRT
NON-FINAL ACTION E-MAILED
12/17/2024
CNRT
NON-FINAL ACTION WRITTEN
12/17/2024
DOCK
ASSIGNED TO EXAMINER
12/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2024
NWAP
NEW APPLICATION ENTERED
06/03/2024
Continuous trademark protection
Get notified about every new filing that threatens WUXI BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.